arrow
U

Urška Arnautovska

The University of Queensland
H指数:18
被引数:1,009

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Protocol for the MyPREPED trial: hybrid type 2 effectiveness–implementation trial of a peer-delivered digital self-management tool (MyBRANCHES) for young people in Australia transitioning from early intervention in psychosis services

澳大利亚精神早期干预服务过渡期青年人群同伴支持数字自我管理工具(MyBRANCHES)混合型2类效果-实施试验的方案:MyPREPED试验

2026-10-070
OAAI
A multidisciplinary perspective on digital health interventions in schizophrenia care: Expanding the 2026 Grading of Recommendations, Assessment, Development and Evaluations guidelines

对精神分裂症护理中数字健康干预措施的多学科视角:扩展2026年推荐、评估、制定和评价分级指南

2026-09-280
PRE
Duration of untreated illness in eating disorders: a comprehensive systematic review and meta-regression

进食障碍的未治疗病程:一项全面的系统综述和元回归分析

2026-08-190
OA
SMART: preliminary efficacy; feasibility and acceptability of a theory-informed digital intervention for metabolic health in people with schizophrenia and related disorders

SMART研究:基于理论指导的数字干预措施对精神分裂症及相关障碍患者代谢健康的初步疗效、可行性与可接受性

2026-04-270
OA
An Effectiveness Trial of an Exercise Physiologist Service to Improve Quality of Life in Adults with Severe Mental Illness: Protocol for the MOVEMENT Study

一项运动生理学家服务以提高严重精神疾病成人生活质量的有效性试验:MOVEMENT研究的方案

2025-07-110
OA
A Novel Digital Intervention to Facilitate Diabetes Self-Management Among People with Schizophrenia and Related Disorders: Development and Acceptability Testing of SMART

一种新型数字干预措施,用于促进精神分裂症及相关障碍患者中的糖尿病自我管理:SMART的开发与可接受性测试

2025-06-260
OA
Efficacy and safety of semaglutide versus placebo for people with schizophrenia on clozapine with obesity (COaST): a phase 2, multi-centre, participant and investigator- blinded, randomised controlled trial in Australia

司美格鲁肽相对于安慰剂在服用氯氮平并伴有肥胖的精神分裂症患者中的疗效与安全性(COaST):一项在澳大利亚进行的第2阶段、多中心、参与者与研究者双盲、随机对照试验

2025-06-100
PRE